TXMD
NASDAQ · Pharmaceuticals
Therapeuticsmd Inc
$2.05
+0.04 (+1.99%)
Open$1.97
Previous Close$2.01
Day High$2.10
Day Low$1.96
52W High$2.95
52W Low$0.98
Volume—
Avg Volume20.5K
Market Cap22.92M
P/E Ratio—
EPS$-0.05
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+479.5% upside
Current
$2.05
$2.05
Target
$11.88
$11.88
$7.57
$11.88 avg
$17.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.92M | 8.32M | 4.86M |
| Net Income | -550,013 | -1,410,691 | 1.27M |
| Profit Margin | -18.8% | -17.9% | 26.2% |
| EBITDA | -396,859 | -1,074,425 | 2.17M |
| Free Cash Flow | — | — | 1.08M |
| Rev Growth | -64.9% | -64.9% | +8.5% |
| Debt/Equity | — | — | 0.57 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |